Global and Japan Autoimmune Drugs Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Autoimmune Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Rheumatoid Arthritis (RA)
  • 1.2.3 Multiple Sclerosis (MS)
  • 1.2.4 Psoriasis
  • 1.2.5 Inflammatory Bowel Disease (IBD)
  • 1.2.6 Ankylosing Spondylitis (AS)
  • 1.2.7 Systemic Lupus Erythematosus (SLE)
• 1.3 Market by Application
  • 1.3.1 Global Autoimmune Drugs Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospitals
  • 1.3.3 Homecare Settings
  • 1.3.4 Specialty Clinics
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Autoimmune Drugs Market Perspective (2015-2026)
• 2.2 Global Autoimmune Drugs Growth Trends by Regions
  • 2.2.1 Autoimmune Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Autoimmune Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 Autoimmune Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Autoimmune Drugs Players by Market Size
  • 3.1.1 Global Top Autoimmune Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global Autoimmune Drugs Revenue Market Share by Players (2015-2020)
• 3.2 Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Autoimmune Drugs Revenue
• 3.4 Global Autoimmune Drugs Market Concentration Ratio
  • 3.4.1 Global Autoimmune Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Drugs Revenue in 2019
• 3.5 Key Players Autoimmune Drugs Area Served
• 3.6 Key Players Autoimmune Drugs Product Solution and Service
• 3.7 Date of Enter into Autoimmune Drugs Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Autoimmune Drugs Breakdown Data by Type (2015-2026)

• 4.1 Global Autoimmune Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global Autoimmune Drugs Forecasted Market Size by Type (2021-2026)

5 Autoimmune Drugs Breakdown Data by Application (2015-2026)

• 5.1 Global Autoimmune Drugs Historic Market Size by Application (2015-2020)
• 5.2 Global Autoimmune Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Autoimmune Drugs Market Size (2015-2026)
• 6.2 North America Autoimmune Drugs Market Size by Type (2015-2020)
• 6.3 North America Autoimmune Drugs Market Size by Application (2015-2020)
• 6.4 North America Autoimmune Drugs Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Autoimmune Drugs Market Size (2015-2026)
• 7.2 Europe Autoimmune Drugs Market Size by Type (2015-2020)
• 7.3 Europe Autoimmune Drugs Market Size by Application (2015-2020)
• 7.4 Europe Autoimmune Drugs Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Autoimmune Drugs Market Size (2015-2026)
• 8.2 China Autoimmune Drugs Market Size by Type (2015-2020)
• 8.3 China Autoimmune Drugs Market Size by Application (2015-2020)
• 8.4 China Autoimmune Drugs Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Autoimmune Drugs Market Size (2015-2026)
• 9.2 Japan Autoimmune Drugs Market Size by Type (2015-2020)
• 9.3 Japan Autoimmune Drugs Market Size by Application (2015-2020)
• 9.4 Japan Autoimmune Drugs Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Autoimmune Drugs Market Size (2015-2026)
• 10.2 Southeast Asia Autoimmune Drugs Market Size by Type (2015-2020)
• 10.3 Southeast Asia Autoimmune Drugs Market Size by Application (2015-2020)
• 10.4 Southeast Asia Autoimmune Drugs Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Eli Lilly
  • 11.1.1 Eli Lilly Company Details
  • 11.1.2 Eli Lilly Business Overview
  • 11.1.3 Eli Lilly Autoimmune Drugs Introduction
  • 11.1.4 Eli Lilly Revenue in Autoimmune Drugs Business (2015-2020))
  • 11.1.5 Eli Lilly Recent Development
• 11.2 GSK
  • 11.2.1 GSK Company Details
  • 11.2.2 GSK Business Overview
  • 11.2.3 GSK Autoimmune Drugs Introduction
  • 11.2.4 GSK Revenue in Autoimmune Drugs Business (2015-2020)
  • 11.2.5 GSK Recent Development
• 11.3 AbbVie
  • 11.3.1 AbbVie Company Details
  • 11.3.2 AbbVie Business Overview
  • 11.3.3 AbbVie Autoimmune Drugs Introduction
  • 11.3.4 AbbVie Revenue in Autoimmune Drugs Business (2015-2020)
  • 11.3.5 AbbVie Recent Development
• 11.4 Johnson & Johnson
  • 11.4.1 Johnson & Johnson Company Details
  • 11.4.2 Johnson & Johnson Business Overview
  • 11.4.3 Johnson & Johnson Autoimmune Drugs Introduction
  • 11.4.4 Johnson & Johnson Revenue in Autoimmune Drugs Business (2015-2020)
  • 11.4.5 Johnson & Johnson Recent Development
• 11.5 Biogen
  • 11.5.1 Biogen Company Details
  • 11.5.2 Biogen Business Overview
  • 11.5.3 Biogen Autoimmune Drugs Introduction
  • 11.5.4 Biogen Revenue in Autoimmune Drugs Business (2015-2020)
  • 11.5.5 Biogen Recent Development
• 11.6 Amgen
  • 11.6.1 Amgen Company Details
  • 11.6.2 Amgen Business Overview
  • 11.6.3 Amgen Autoimmune Drugs Introduction
  • 11.6.4 Amgen Revenue in Autoimmune Drugs Business (2015-2020)
  • 11.6.5 Amgen Recent Development
• 11.7 Pfizer
  • 11.7.1 Pfizer Company Details
  • 11.7.2 Pfizer Business Overview
  • 11.7.3 Pfizer Autoimmune Drugs Introduction
  • 11.7.4 Pfizer Revenue in Autoimmune Drugs Business (2015-2020)
  • 11.7.5 Pfizer Recent Development
• 11.8 Roche
  • 11.8.1 Roche Company Details
  • 11.8.2 Roche Business Overview
  • 11.8.3 Roche Autoimmune Drugs Introduction
  • 11.8.4 Roche Revenue in Autoimmune Drugs Business (2015-2020)
  • 11.8.5 Roche Recent Development
• 11.9 Baxter
  • 11.9.1 Baxter Company Details
  • 11.9.2 Baxter Business Overview
  • 11.9.3 Baxter Autoimmune Drugs Introduction
  • 11.9.4 Baxter Revenue in Autoimmune Drugs Business (2015-2020)
  • 11.9.5 Baxter Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer